1 Versus 2 Hours Post Meal Glucose Monitoring in Gestational Diabetes on Treatment
Launched by NATIONAL UNIVERSITY OF MALAYSIA · Apr 6, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how often women with gestational diabetes should check their blood sugar levels after meals. Specifically, it compares checking blood sugar one hour after eating versus two hours after eating. The goal is to see which timing helps manage blood sugar better for women who are receiving treatment, either with a medication called metformin alone or in combination with insulin.
To participate in this study, women need to have been diagnosed with gestational diabetes and require treatment. Unfortunately, those with type 1 or type 2 diabetes, certain serious pregnancy complications, or specific medical conditions like systemic lupus erythematosus cannot join. If eligible, participants will join a group that will help determine the best timing for blood sugar monitoring after meals. This research can provide valuable insights that may help improve care for women with gestational diabetes in the future.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Gestational diabetes diagnosed based on National Institute for Health and Care Excellence guideline
- • requiring treatment either with metformin alone or combined with insulin
- Exclusion Criteria:
- • type 1 and 2 diabetes
- • bad obstetrics history
- • underlying medical disorders such as Systemic Lupus Erythematosus
- • fetal anomaly
- • delivery elsewhere
About National University Of Malaysia
The National University of Malaysia (Universiti Kebangsaan Malaysia, UKM) is a prestigious institution dedicated to advancing medical research and clinical trials that contribute significantly to the fields of healthcare and biomedical sciences. As a leading academic and research university, UKM is committed to fostering innovation and excellence in clinical research, promoting collaboration among multidisciplinary teams, and enhancing the quality of patient care. The university's robust infrastructure and experienced research faculty facilitate rigorous clinical trials aimed at addressing critical health challenges, thereby improving health outcomes both locally and globally. Through its dedication to ethical research practices and adherence to regulatory standards, UKM strives to enhance the understanding of diseases and develop effective interventions that benefit society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kuala Lumpur, W.Persekutuan, Malaysia
Patients applied
Trial Officials
Rahana Abd Rahman
Principal Investigator
National University of Malaysia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials